Roche's Spark in­vests $575M for new gene ther­a­py cen­ter in cen­tral Philadel­phia as part of Drex­el part­ner­ship

Roche’s Spark Ther­a­peu­tics is tak­ing a big new step in gene ther­a­py de­vel­op­ment, a field where it’s known as an ear­ly pi­o­neer.

Spark will in­vest $575 mil­lion to build a new “gene ther­a­py in­no­va­tion cen­ter” on the Drex­el Uni­ver­si­ty cam­pus in Philadel­phia, the com­pa­ny an­nounced Fri­day morn­ing. The plan in­cludes a 99-year lease for 500,000 square feet of land, with con­struc­tion ex­pect­ed to be­gin in the fourth quar­ter of 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER